Hidden features within the spleen detected on abdominal imaging scans can signal a person’s risk of developing coronary artery disease, according to a new study published in Science Translational Medicine. Led by investigators from Mass General Brigham, the research leverages artificial intelligence and genomic analyses to uncover how blood-forming and immune functions in the spleen … Read more
According to research published in Lancet Digital Health on September 1, 2026, scientists at Scripps Research have developed a new artificial intelligence tool called ECG-CLIP to detect and predict heart diseases using less hand-labeled data than traditional models. Built using over 1.7 million electrocardiograms collected from more than 540,000 people and paired with clinicians’ notes, … Read more
Coronary artery calcium (CAC) scoring and traditional risk factor assessment via pooled cohort equations yield similar rates of major cardiovascular events when used to guide statin initiation for primary prevention, according to clinical trial results presented at the European Society of Cardiology Congress. Cardiovascular diseases remain the leading global cause of morbidity and mortality, driven … Read more
According to the European Society of Cardiology, non-vitamin K antagonist oral anticoagulant (NOAC) therapy reduces imaging signs of clot formation on new heart valves by 45% compared with antiplatelet therapy following transcatheter aortic valve implantation (TAVI), without compromising patient safety. ACASA-TAVI Trial Results Presented at ESC Congress 2026 The ACASA-TAVI trial, presented during a Hot … Read more
Transcatheter tricuspid valve repair significantly improves clinical outcomes and quality of life for high-risk patients suffering from severe tricuspid regurgitation, according to results presented at the ESC Congress 2026 and published simultaneously in the New England Journal of Medicine. Transcatheter tricuspid valve repair combined with medical therapy significantly cuts heart failure hospitalizations and all-cause death … Read more
A TAVI-first strategy for patients with severe aortic stenosis and concomitant coronary artery disease is noninferior to a PCI-first approach at one year, according to clinical trial results presented at the ESC Congress 2026 and published simultaneously in the New England Journal of Medicine. Researchers evaluated 986 patients across 48 centers to compare the competing … Read more
Atorvastatin reduced major cardiovascular events by 30 percent in older adults without known cardiovascular disease, diabetes, or dementia, according to findings presented at the ESC Congress 2026 and published in the New England Journal of Medicine. Led by researchers at Monash University, the STAREE trial evaluated 9,971 participants aged 70 and older over a median … Read more
Radiation exposure to the thymus during non-small cell lung cancer treatment is associated with worse outcomes in patients being treated for non-small cell lung cancer (NSCLC), according to a study published in the journal Annals of Oncology. Thymus Health and Radiation Risks in NSCLC Patients Until recently, the thymus was thought to be of little … Read more
According to a narrative review published in the journal Nutrients by researchers in Australia and Croatia, the long-debated J-shaped association between moderate wine consumption and lower all-cause mortality remains biologically plausible, though methodological differences heavily shape contemporary public health guidelines. Stockley, Arthur C. Ellison, and Mirela Boban synthesized studies published primarily between 1980 and March … Read more
A new international study reveals that global tobacco control campaigns have failed to bridge a critical knowledge gap over two decades, leaving millions of smokers unaware that tobacco causes heart attacks, strokes, and cardiovascular disease. According to research published in BMJ Open by teams at the University of Waterloo and the U.S. Centers for Disease … Read more